1. Preface

• 1.1 Report Description and Scope

• 1.2 Research Objectives

• 1.3 Key Questions Answered in This Report

• 1.4 Intended Audience

• 1.5 Currency and Pricing Conventions Used

2. Executive Summary

• 2.1 Global Gene Amplification Technology Market Snapshot

• 2.2 Key Findings and Highlights

• 2.3 Market Attractiveness Analysis by Segment

• 2.4 Technological Transformation: From Conventional PCR to Digital PCR, LAMP, and AI-Integrated Genomics Workflows

• 2.5 Analyst Recommendations

3. Market Introduction

• 3.1 Definition and Scope of Gene Amplification Technologies

• 3.1.1 Core Principle: Selective Enzymatic Replication of Target DNA/RNA Sequences for Detection, Quantification, and Analysis

• 3.1.2 Distinction Between In Vitro Gene Amplification, In Vivo Oncogene Amplification, and Gene Copy Number Variation (CNV)

• 3.2 Historical Evolution of Gene Amplification Technologies

• 3.2.1 From Original Kary Mullis PCR Discovery (1983) to Real-Time qPCR, Digital PCR, and Multiplex Isothermal Platforms

• 3.2.2 COVID-19 Pandemic as a Catalytic Event for Rapid Mass Adoption of PCR and LAMP Diagnostics Globally

• 3.3 Classification of Gene Amplification Technologies

• 3.3.1 Thermal Cycling-Based Systems (Conventional PCR, RT-PCR, qPCR, Digital PCR, Multiplex PCR)

• 3.3.2 Isothermal Amplification Systems (LAMP, NASBA, SDA, RCA, RPA, HDA)

• 3.3.3 Next-Generation Amplification for Sequencing (Library Preparation — Whole Genome Amplification, Whole Exome Amplification, Single-Cell Amplification)

• 3.4 Key Components of Gene Amplification Workflows

• 3.4.1 Sample Collection, Extraction, and Nucleic Acid Purification

• 3.4.2 Amplification Instruments: Thermal Cyclers, Real-Time PCR Machines, Digital PCR Platforms, Isothermal Reactors

• 3.4.3 Kits, Reagents, and Enzymes: DNA Polymerases, Primers, Probes, Master Mixes, Reverse Transcriptases

• 3.4.4 Software, Bioinformatics, and Cloud-Based Data Analysis Platforms

• 3.5 Regulatory and Standards Framework

• 3.5.1 U.S. FDA: EUA (Emergency Use Authorization) and PMA (Pre-Market Approval) Pathways for PCR/LAMP-Based Diagnostics

• 3.5.2 European Medicines Agency (EMA) and CE-IVD Marking Compliance for Gene Amplification Diagnostic Kits

• 3.5.3 WHO Prequalification Program for Nucleic Acid Amplification Testing (NAAT) Diagnostics

• 3.5.4 Clinical Laboratory Improvement Amendments (CLIA) and CAP Accreditation Standards (United States)

• 3.5.5 China NMPA Regulatory Pathway for Genetic Testing Reagents and IVD Approval

• 3.6 Value Chain Analysis

• 3.6.1 Raw Material and Chemical Suppliers (Enzymes, Nucleotides, Primers, Fluorescent Dyes)

• 3.6.2 Instrument and Equipment Manufacturers

• 3.6.3 Kit and Reagent Formulators (Commercial and Custom)

• 3.6.4 Software and Bioinformatics Platform Developers

• 3.6.5 Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)

• 3.6.6 End-User Laboratories: Clinical, Research, Forensic, Agricultural, Food Safety

• 3.7 Industry Ecosystem Map

4. Research Methodology

• 4.1 Research Design and Framework

• 4.2 Primary and Secondary Data Sources

• 4.3 Data Triangulation and Validation Approach

• 4.4 Market Size Estimation and Forecasting Methodology

• 4.5 Assumptions and Limitations

• 4.6 List of Abbreviations

5. Market Dynamics

• 5.1 Market Drivers

• 5.1.1 Increasing Demand for Precision and Early Disease Diagnostics — Rising Prevalence of Infectious Diseases, Cancer, and Genetic Disorders Driving Molecular Testing Volumes (320 PCR-Based Clinical Trials Running in the U.S. in 2023 Alone)

• 5.1.2 Rapid Growth of Personalized Medicine and Companion Diagnostics — Gene Amplification as the Core Tool for Genetic Profiling and Treatment Tailoring

• 5.1.3 Expanding Applications in Forensic Science, Paternity Testing, Agricultural Biotechnology, and Food Safety GMO Detection

• 5.1.4 Rising Investments in Genomics Research and Increasing Government Funding for Biotech R&D Infrastructure

• 5.1.5 Advancements in Digital PCR, Microfluidics, and Miniaturized Point-of-Care Amplification Platforms for Decentralized Molecular Testing

• 5.1.6 Growing Adoption of Next-Generation Sequencing (NGS) Creating Upstream Demand for High-Quality Gene Amplification Library Preparation Kits

• 5.1.7 Integration of AI and Machine Learning in Gene Amplification Workflows — Automated Data Analysis, Primer Design Optimization, and Genomic Variant Interpretation

• 5.2 Market Restraints

• 5.2.1 Prohibitive Instrument Costs, Reagent Expenses, and Infrastructure Requirements Limiting Adoption in Low-and Middle-Income Countries (LMICs)

• 5.2.2 Regulatory Complexity and Prolonged Approval Processes Delaying Commercialization of Innovative Gene Amplification Diagnostics

• 5.2.3 Ethical Concerns Regarding Genetic Privacy, Data Security, and Potential Misuse of Genetic Information Limiting Broad Public Acceptance

• 5.2.4 Technical Challenges: Contamination Risk, Non-Specific Amplification, and Inhibitor Interference Affecting Assay Reliability

• 5.3 Market Opportunities

• 5.3.1 Point-of-Care (POC) Gene Amplification: Rapid LAMP and Microfluidic PCR Devices for Decentralized Testing in Hospitals, Clinics, Remote Settings, and Home Use

• 5.3.2 Single-Cell Gene Amplification Technologies for Tumor Heterogeneity Analysis, Liquid Biopsy, and Rare Cell Detection (Bio-Rad ddSEQ Single-Cell 3' RNA-Seq Kit Launch, June 2024)

• 5.3.3 Agricultural Genomics Expansion: Gene Amplification for Crop Improvement, Disease Resistance, GMO Verification, and Soil Microbiome Characterization

• 5.3.4 Emerging Markets: Asia Pacific and Latin America — Increasing Healthcare Infrastructure Investment, Affordable Skilled Workforce, and Expanding Biotech R&D Hubs (China, India)

• 5.3.5 Gene Therapy Pipeline Support: Whole Genome and Plasmid DNA Amplification for AAV Vector Manufacturing (4basebio Non-Viral Nanoparticle Platform)

• 5.4 Market Challenges

• 5.4.1 Managing and Interpreting Large Datasets Generated by High-Throughput Amplification Platforms — Need for Advanced Bioinformatics and Cloud Infrastructure

• 5.4.2 Cold Chain and Reagent Stability Challenges for Deployment in Tropical, Resource-Limited Settings

• 5.4.3 Increasing Competition from Alternative Molecular Diagnostic Technologies (CRISPR-Based Diagnostics, Direct Nanopore Sequencing Without Amplification)

• 5.5 Porter's Five Forces Analysis

• 5.5.1 Threat of New Entrants

• 5.5.2 Bargaining Power of Suppliers (Enzyme and Nucleotide Raw Material Manufacturers, Fluorescent Dye Suppliers)

• 5.5.3 Bargaining Power of Buyers (Pharma/Biotech Companies, Hospitals, Academic Labs, Forensic Labs, Food Safety Labs)

• 5.5.4 Threat of Substitutes (CRISPR-Dx, Direct Hybridization, Nanopore Sequencing, Mass Spectrometry Genetic Testing)

• 5.5.5 Competitive Rivalry Among Existing Players

• 5.6 PESTLE Analysis

• 5.7 Patent Landscape and IP Analysis

• 5.8 Funding Landscape: Venture Capital, NIH/NCI Grants, BARDA, EU Horizon Programs for Genomic Research

• 5.9 COVID-19 Impact and Post-Pandemic Market Normalization Assessment

• 5.10 Pipeline Analysis: Novel Gene Amplification Technologies and Platforms in Research and Pre-Commercial Stages

6. Global Gene Amplification Technology Market Analysis, By Product

• 6.1 Overview and Key Findings

• 6.2 Kits and Reagents (Dominant Product Segment — ~68.1% Market Share in 2023)

• 6.2.1 Market Size and Forecast

• 6.2.2 PCR Master Mixes, RT-PCR Kits, Digital PCR Supermixes, LAMP Reagent Kits

• 6.2.3 DNA/RNA Extraction and Purification Kits

• 6.2.4 Library Preparation Kits for NGS (Illumina, Thermo Fisher, QIAGEN)

• 6.2.5 Single-Cell Amplification Kits (Bio-Rad ddSEQ™ 3' RNA-Seq Kit, June 2024; Takara Bio Shasta Single-Cell System, April 2024)

• 6.3 Instruments

• 6.3.1 Market Size and Forecast

• 6.3.2 Conventional and Gradient Thermal Cyclers

• 6.3.3 Real-Time Quantitative PCR (qPCR/RT-qPCR) Systems

• 6.3.4 Digital PCR (dPCR) Platforms (Droplet Digital PCR — Bio-Rad QX600, Thermo Fisher QuantStudio™ Absolute Q)

• 6.3.5 Isothermal Amplification Instruments (LAMP Analyzers, Genie, Eiken LOOPAMP)

• 6.3.6 Automated Nucleic Acid Extraction and PCR Setup Workstations

• 6.4 Software and Services (Fastest Growing Product Segment — ~2.2% CAGR)

• 6.4.1 Market Size and Forecast

• 6.4.2 Bioinformatics Software: Primer Design, Sequence Alignment, Amplicon Analysis, Variant Calling

• 6.4.3 Cloud-Based Data Management Platforms for High-Throughput Genomic Workflows

• 6.4.4 Laboratory Information Management Systems (LIMS) Integration

• 6.4.5 Outsourced PCR/NGS Library Prep Services, Custom Assay Development, and CRO Services

7. Global Gene Amplification Technology Market Analysis, By Technology

• 7.1 Overview and Key Findings

• 7.2 PCR-Based Amplification (Dominant Technology — ~72.0% Market Share in 2023)

• 7.2.1 Market Size and Forecast

• 7.2.2 Conventional PCR (End-Point, Qualitative Analysis)

• 7.2.3 Real-Time Quantitative PCR (qPCR / RT-qPCR) — Broad Clinical Diagnostics Application

• 7.2.4 Digital PCR (dPCR): Droplet Digital PCR (ddPCR) and Chip-Based dPCR for Absolute Quantification

• 7.2.5 Multiplex PCR (Simultaneous Multi-Target Detection)

• 7.2.6 Allele-Specific PCR, Nested PCR, and Reverse Transcription PCR

• 7.3 Loop-Mediated Isothermal Amplification (LAMP) (Fastest Growing Technology — Key POC Enabler)

• 7.3.1 Market Size and Forecast

• 7.3.2 Principle: Six Primers + Strand Displacement Polymerase — Rapid, Specific Amplification at Constant Temperature

• 7.3.3 LAMP for COVID-19, Tuberculosis, Malaria, and Antimicrobial Resistance (AMR) Detection

• 7.3.4 Key Products: Eiken Chemical LOOPAMP System; Abbott ID NOW; HiberGene LAMP-Based SARS-CoV-2 Test

• 7.4 Nucleic Acid Sequence-Based Amplification (NASBA) (Projected Fastest CAGR of 1.4%)

• 7.4.1 Market Size and Forecast

• 7.4.2 Isothermal RNA Amplification Mimicking Retroviral Replication — High Sensitivity for RNA Targets

• 7.4.3 Applications: HIV Viral Load Monitoring, CMV Detection, Emerging Pathogen RNA Surveillance

• 7.5 Strand Displacement Amplification (SDA)

• 7.5.1 Market Size and Forecast

• 7.5.2 Applications: Chlamydia, Gonorrhea, and STI Molecular Diagnostics (BD ProbeTec ET System)

• 7.6 Multiple Displacement Amplification (MDA)

• 7.6.1 Market Size and Forecast

• 7.6.2 Whole Genome Amplification from Minimal DNA Input — Single-Cell Genomics, FFPE Samples

• 7.7 Rolling Circle Amplification (RCA)

• 7.7.1 Market Size and Forecast

• 7.7.2 Applications: Circular DNA/RNA Amplification, SNP Genotyping, Proximity Ligation Assays

• 7.8 Ramification Amplification Method (RAM)

• 7.8.1 Market Size and Forecast

• 7.9 Others (Helicase-Dependent Amplification (HDA), Recombinase Polymerase Amplification (RPA), Transcription-Mediated Amplification (TMA), Nicking Enzyme Amplification Reaction (NEAR))

8. Global Gene Amplification Technology Market Analysis, By Application (Downstream)

• 8.1 Overview and Key Findings

• 8.2 Diagnostics and Pharmaceutical (Dominant Application — ~72.7% Market Share in 2023)

• 8.2.1 Market Size and Forecast

• 8.2.2 Infectious Disease Diagnostics: Respiratory Pathogens (COVID-19, Influenza, RSV), Sexually Transmitted Infections, Tuberculosis, Hepatitis B/C, HIV

• 8.2.3 Oncology / Cancer Diagnostics: Tumor Mutation Burden (TMB), Liquid Biopsy (ctDNA), HER2 Amplification, KRAS/BRAF/EGFR Oncogene Copy Number Analysis

• 8.2.4 Genetic Disease and Rare Disease Testing: Prenatal Diagnostics (NIPT), Newborn Screening, Carrier Status Testing

• 8.2.5 Pharmacogenomics (PGx): Drug Metabolism Gene Panel Testing for Personalized Medicine

• 8.2.6 Drug Discovery and Development: Target Identification, Functional Genomics, Biomarker Validation

• 8.3 Forensic and Paternity Testing (Fastest Growing Application — 2.1% CAGR)

• 8.3.1 Market Size and Forecast

• 8.3.2 STR (Short Tandem Repeat) Profiling for Forensic DNA Evidence Analysis

• 8.3.3 Paternity and Kinship Identification; Missing Persons DNA Databases

• 8.3.4 Government and Law Enforcement Investment in Compact Field-Deployable PCR Platforms

• 8.4 Agricultural and Food Safety

• 8.4.1 Market Size and Forecast

• 8.4.2 GMO/LMO Detection and Quantification for Regulatory Compliance

• 8.4.3 Crop Disease and Pathogen Identification (PCR-Based Plant Diagnostics)

• 8.4.4 Food Authentication, Species Identification, and Adulteration Detection

• 8.4.5 Animal Breeding, Livestock Genomics, and Veterinary Diagnostics

• 8.5 Others (Environmental Monitoring, Biosecurity/Biodefense, Microbiome Research, Gene Therapy Manufacturing)

9. Global Gene Amplification Technology Market Analysis, By Sample Type

• 9.1 Overview and Key Findings

• 9.2 Cell Lines (Dominant Sample Type — ~39.8% Market Share in 2023)

• 9.2.1 Market Size and Forecast

• 9.2.2 Broad Commercial Kit Availability, Low Cost, and High Reproducibility

• 9.2.3 Applications: In Vitro Drug Testing, Gene Expression Profiling, Cancer Biology Research

• 9.3 Body Fluids (Blood, Plasma, Serum, Urine, CSF, Saliva)

• 9.3.1 Market Size and Forecast

• 9.3.2 Liquid Biopsy: cfDNA/ctDNA Extraction and Amplification for Non-Invasive Cancer Monitoring

• 9.3.3 Viral Load Measurement from Plasma (HIV, HBV, HCV, CMV)

• 9.4 Tissue (FFPE, Fresh Frozen, Core Needle Biopsy)

• 9.4.1 Market Size and Forecast

• 9.4.2 Oncology Companion Diagnostics and Tumor Gene Amplification Status Testing

• 9.5 Agricultural and Food Samples (Fastest Growing Sample Type Segment)

• 9.5.1 Market Size and Forecast

• 9.5.2 Plant Tissue, Seed, Grain, and Processed Food Sample Analysis

• 9.5.3 Environmental Swabs and Soil Microbiome Samples

• 9.6 Others (Forensic Swabs, Environmental Water Samples, Air Particulate, Single Cells)

10. Global Gene Amplification Technology Market Analysis, By End Use

• 10.1 Overview and Key Findings

• 10.2 Academic and Research Institutes (Dominant End-Use Segment — ~26.8% Market Share in 2023)

• 10.2.1 Market Size and Forecast

• 10.2.2 Fundamental Molecular Biology Research: Gene Cloning, Expression Analysis, Functional Genomics

• 10.2.3 Government Grants (NIH, BARDA, EU Horizon Europe) Supporting Genomics Research Infrastructure

• 10.3 Pharmaceutical and Biotechnology Companies

• 10.3.1 Market Size and Forecast

• 10.3.2 Drug Target Identification and Validation (CRISPR Screens, RNA-Seq, ChIP-seq)

• 10.3.3 Companion Diagnostic and Pharmacogenomics Assay Development

• 10.3.4 Gene Therapy and mRNA Therapy Manufacturing (Plasmid and Template DNA Amplification)

• 10.4 Forensic Laboratories (Second Largest Segment — ~24.9% Market Share in 2023)

• 10.4.1 Market Size and Forecast

• 10.4.2 National DNA Databases (CODIS in the U.S., NDNAD in the UK) Driving High-Volume PCR Demand

• 10.4.3 Portable and Field-Deployable PCR Systems for Rapid On-Site Forensic Analysis

• 10.5 Hospitals and Diagnostic Laboratories

• 10.5.1 Market Size and Forecast

• 10.5.2 Centralized Clinical Microbiology Laboratories for High-Volume PCR Pathogen Testing

• 10.5.3 Molecular Pathology: Tumor Biomarker Testing, Genetic Disease Screening

• 10.6 Contract Research Organizations (CROs)

• 10.6.1 Market Size and Forecast

• 10.6.2 Outsourced Genomic Services: Custom Assay Development, NGS Library Prep, PCR Validation Studies

• 10.7 Others (Food and Environmental Testing Laboratories, Veterinary Diagnostic Labs, Government Health Agencies)

11. Global Gene Amplification Technology Market Analysis, By Region

• 11.1 Overview and Regional Key Findings

• 11.2 North America (Dominant Region — U.S. Holds ~84.2% of North America Market)

• 11.2.1 Market Size and Forecast

• 11.2.2 United States

• 11.2.2.1 Market Size and Forecast

• 11.2.2.2 World's Largest Installed Base of PCR Instruments; 320 PCR-Based Clinical Trials Running in 2023

• 11.2.2.3 FDA EUA and PMA Approval Framework — Strong Molecular Diagnostics Market Regulatory Infrastructure

• 11.2.2.4 Dominant Presence of Global Technology Leaders: Thermo Fisher Scientific, Bio-Rad, QIAGEN, Illumina, Danaher (Cepheid), New England Biolabs, Promega

• 11.2.3 Canada

• 11.2.3.1 Market Size and Forecast

• 11.2.3.2 Growing Investment in Genomics Research (Genome Canada) and National Biobank Infrastructure

• 11.2.4 Mexico

• 11.2.4.1 Market Size and Forecast

• 11.3 Europe (~26.3% Market Share in 2023 — Major Manufacturing and R&D Hub)

• 11.3.1 Market Size and Forecast

• 11.3.2 Germany — QIAGEN Headquarters (Hilden); Merck KGaA (Darmstadt); Strong Industrial Biotechnology Sector

• 11.3.2.1 Market Size and Forecast

• 11.3.3 United Kingdom — NHS Clinical Genomics; Rapid DNA Sequencing and Forensic Amplification Technology Development; LGC Group Headquarters

• 11.3.4 France — Institut Pasteur and INSERM-Funded Molecular Diagnostics R&D

• 11.3.5 Italy — Menarini Silicon Biosystems (Bologna); Advanced IVD Market

• 11.3.6 Spain

• 11.3.7 Scandinavia (Denmark, Sweden, Norway) — Nordic Biobank Initiatives and Precision Medicine Programs

• 11.3.8 Rest of Europe

• 11.4 Asia Pacific (Fastest Growing Region — China, India, South Korea, Japan Driving Growth)

• 11.4.1 Market Size and Forecast

• 11.4.2 China

• 11.4.2.1 Market Size and Forecast

• 11.4.2.2 Substantial Market Share in 2023; High WGA Demand; Government Healthcare Programs; Yikang Gene and Vazyme Biotech as Domestic PCR Players

• 11.4.3 India

• 11.4.3.1 Market Size and Forecast

• 11.4.3.2 Largest Skilled Biotech Workforce at Affordable Cost; Expanding IVD Manufacturing Sector; National Genomics Grid

• 11.4.4 Japan — Takara Bio Inc. (Kusatsu); Eiken Chemical LOOPAMP LAMP Technology; Precision Medicine Policy

• 11.4.5 South Korea — Samsung Biologics CRO PCR Capabilities; GC Genome Precision Diagnostics

• 11.4.6 Australia — Genomics Australia National Initiative; Cyclopharm Molecular Diagnostics

• 11.4.7 Thailand and ASEAN Countries

• 11.4.8 Rest of Asia Pacific

• 11.5 Latin America

• 11.5.1 Market Size and Forecast

• 11.5.2 Brazil — FIOCRUZ National PCR Diagnostic Network; Growing Agricultural GMO Testing Market

• 11.5.3 Mexico

• 11.5.4 Argentina

• 11.5.5 Rest of Latin America

• 11.6 Middle East and Africa

• 11.6.1 Market Size and Forecast

• 11.6.2 Saudi Arabia — Vision 2030 Healthcare Modernization Driving Molecular Diagnostics Investment

• 11.6.3 UAE — Dubai Genomics Program and COVID-19 PCR Testing Legacy Infrastructure

• 11.6.4 South Africa — African Genomics Network and Pathogen Surveillance Programs

• 11.6.5 Kuwait and GCC Countries

• 11.6.6 Rest of Middle East and Africa

12. Competitive Landscape

• 12.1 Global Market Share Analysis by Key Players

• 12.2 Competitive Benchmarking Matrix (Technology Portfolio Breadth, PCR vs. Isothermal vs. NGS Coverage, Automation Level, Global Distribution Reach)

• 12.3 Vendor Positioning Grid (Global Full-Portfolio Leaders, PCR Instrument Specialists, Isothermal POC Disruptors, Niche Reagent/Kit Providers, Emerging Biotech Players)

• 12.4 Key Strategic Developments

• 12.4.1 New Product Launches (Bio-Rad ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Software, June 2024; Takara Bio Shasta Single-Cell NGS System, April 2024)

• 12.4.2 Mergers and Acquisitions (Danaher Corporation Spinoff of Verint/Life Sciences Division; Thermo Fisher–PPD CRO Integration for Genomic Services)

• 12.4.3 Strategic Partnerships and Licensing Agreements (4basebio Non-Viral Gene Therapy DNA Platform Licensing; Eiken Chemical LOOPAMP Sublicensing for COVID-19 POC Testing)

• 12.4.4 Geographic Expansion: China, India, and ASEAN Biotech Market Entry Strategies

• 12.4.5 R&D Investments: AI-Driven Primer Design, Microfluidic Digital PCR, Single-Cell Amplification Innovation

• 12.5 Patent Landscape and Technology IP Analysis

• 12.6 Market Concentration Analysis

13. Company Profiles

The final report includes a complete list of companies.

• 13.1 Thermo Fisher Scientific Inc.

  • 13.1.1 Company Overview

  • 13.1.2 Financial Performance

  • 13.1.3 Product Portfolio

  • 13.1.4 Strategic Initiatives

  • 13.1.5 SWOT Analysis

• 13.2 QIAGEN N.V.

• 13.3 Bio-Rad Laboratories, Inc.

• 13.4 F. Hoffmann-La Roche AG (Roche Diagnostics)

• 13.5 Illumina, Inc.

• 13.6 Danaher Corporation (Cepheid, Integrated DNA Technologies)

• 13.7 Merck KGaA (MilliporeSigma)

• 13.8 Agilent Technologies, Inc.

• 13.9 New England Biolabs (NEB)

• 13.10 Takara Bio Inc.

• 13.11 Promega Corporation

• 13.12 Abbott Laboratories (Abbott Molecular)

• 13.13 bioMérieux S.A.

• 13.14 LGC Group (Biosearch Technologies)

• 13.15 4basebio AG

14. Recent Developments and Industry News

• 14.1 Key Product Launches and Regulatory Approvals (2024–2026)

• 14.2 Mergers, Acquisitions, and Strategic Alliances

• 14.3 R&D Breakthroughs: Digital PCR, Single-Cell Amplification, AI-Integrated Genomics, CRISPR-PCR Hybrid Diagnostics

• 14.4 Regulatory and Policy Updates: FDA, EMA, WHO NAAT Prequalification, NMPA China

15. Appendix

• 15.1 Detailed Research Methodology

• 15.2 Gene Amplification Technology Reference Table (Principle, Temperature Requirement, Accuracy, Time-to-Result, Key Applications)

• 15.3 List of Tables and Figures

• 15.4 List of Abbreviations

• 15.5 Data Sources and References

• 15.6 About the Publisher

16. Disclaimer